Accounts Receivable turnover ratio remained unchanged during the second quarter 2026, compared to the previous quarter at 3.37 indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Average collection period, for Krystal Biotech Inc 's accounts receivable remained unchanged at 108 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 467 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3108, from overall ranking in the first quarter 2026 at 3585.

What is Receivable Turnover Ratio?
What is Krystal Biotech Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

KRYS Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	24.43 %	23.01 %	21.65 %	33.23 %	7.95 %
Y / Y Revenue Change	24.14 %	31.95 %	17.52 %	16.65 %	36.65 %
Receivable Turnover Ratio (TTM)	3.37	3.37	3.3	3.32	3.45
KRYS's Total Ranking	# 3108	# 3585	# 3207	# 3195	# 3262
Accounts Receivable average collection period days	108	108	111	110	106
Seq. Receivable Change	9.16 %	-0.32 %	-1.7 %	16.33 %	7.92 %
Seq. Revenue Change	2.46 %	8.64 %	9.51 %	1.83 %	8.91 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 53
Healthcare Sector	# 468
Overall Market	# 3108

Receivable Turnover Ratio Statistics
High	Average	Low
3.45	3.34	3.26
(Jun 30 2025)		(Mar 31 2025)

KRYS Company Profile • Back to KRYS Efficiency Comparisons • Compare KRYS Receivables Turnover Ratio to its Competitors

Financial Statements
Krystal Biotech Inc 's Accounts Receivable	$ 139 Millions	Visit KRYS's Balance sheet
Krystal Biotech Inc 's Sales TTM	$ 440 Millions	Visit KRYS's Income Statement
Sources of KRYS's Revenues		Visit KRYS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KRYS's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KRYS's Growth Rates	KRYS's Roa	KRYS's Inventory Turnover Ratio	KRYS's Dividend Comparisons
KRYS's Profitability Ratios	KRYS's Roi	KRYS's Asset Turnover Ratio	KRYS's Dividend Growth
KRYS's Valuation Ratios	KRYS's Roe	KRYS's Financial Strength Ratios	KRYS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Cannapharmarx Inc	8.65	$ 1.699 Millions	$ 0.196 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Septerna Inc	8.64	$ 98.882 Millions	$ 11.445 Millions
10x Genomics Inc	8.63	$ 616.566 Millions	$ 71.463 Millions
Cg Oncology Inc	8.61	$ 6.228 Millions	$ 0.724 Millions
Tactile Systems Technology Inc	8.58	$ 350.319 Millions	$ 40.851 Millions
Pediatrix Medical Group Inc	8.54	$ 1,950.625 Millions	$ 228.297 Millions
Volitionrx Limited	8.50	$ 2.458 Millions	$ 0.289 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions
Inogen Inc	8.47	$ 354.304 Millions	$ 41.817 Millions
Axogen inc	8.42	$ 251.174 Millions	$ 29.846 Millions
Pulse Biosciences Inc	8.35	$ 1.185 Millions	$ 0.142 Millions
Alpha Teknova Inc	8.33	$ 43.407 Millions	$ 5.208 Millions
Rockwell Medical inc	8.31	$ 69.827 Millions	$ 8.400 Millions
Inspire Medical Systems inc	8.25	$ 899.227 Millions	$ 109.027 Millions
Sonoma Pharmaceuticals Inc	8.24	$ 21.920 Millions	$ 2.661 Millions
Madrigal Pharmaceuticals Inc	8.19	$ 1,283.940 Millions	$ 156.857 Millions
X4 Pharmaceuticals Inc	8.17	$ 9.441 Millions	$ 1.156 Millions
Adapthealth Corp	8.14	$ 3,226.709 Millions	$ 396.643 Millions
Seastar Medical Holding Corp	8.11	$ 1.713 Millions	$ 0.211 Millions
Bioage Labs Inc	8.09	$ 10.355 Millions	$ 1.280 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Concentra Group Holdings Parent Inc	8.07	$ 2,287.465 Millions	$ 283.300 Millions
Penumbra Inc	8.06	$ 1,504.874 Millions	$ 186.788 Millions
Sanuwave Health Inc	8.04	$ 43.903 Millions	$ 5.461 Millions
Sight Sciences Inc	8.04	$ 83.351 Millions	$ 10.368 Millions
Aveanna Healthcare Holdings Inc	8.03	$ 2,602.820 Millions	$ 324.026 Millions
Sotera Health Company	8.01	$ 1,215.925 Millions	$ 151.745 Millions
Avita Medical Inc	7.99	$ 75.631 Millions	$ 9.463 Millions
Alphatec Holdings Inc	7.94	$ 814.780 Millions	$ 102.662 Millions

Date modified: 2026-09-12T18:37:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.